It’s irrelevant given the PR I quoted and further that the data is included in the JAMA Paper supplement materials. I mentioned that as an aside, that they would have that option. And no, I think you’re wrong on storage of the tumor once the vaccine is made. I doubt very highly they ship the tumor back to a doctor’s office.
Your quote is related to the post trial, specials program/ pre commercialization stage, not the trial.
Market Data 
Markets 
AI
